Prenatal diagnosis of haemoglobin disorders by cordocentesis at 12 weeks' gestation.
Prenatal diagnosis of haemoglobin disorders is accepted to be a useful procedure to avoid births of infants with homozygous diseases. Advances in sampling and molecular techniques, such as polymerase chain reaction (PCR) and chorionic villus sampling (CVS), have made earlier and safer first-trimester prenatal diagnosis possible. However, these procedures need previous studies of at-risk couples, which can be very time-consuming when a number of different beta-thalassaemia mutations occur in the region. We describe the possibility of making a first-trimester prenatal diagnosis by cordocentesis and fetal blood analysis at the 12th week of gestation. We found no statistically significant difference (p greater than 0.05) between beta/gamma values in fetuses at the 12th and 18th weeks of gestation. In seven affected fetuses aborted at the 12th week of gestation, the diagnosis was confirmed in all cases by PCR analysis. These findings suggest that early cordocentesis could be an alternative procedure to CVS and PCR analysis.
Trapani
F D
FD
Department of Haematology, V. Cervello Hospital, Palermo, Italy.
Marino
M
M
D'Alcamo
E
E
Abate
I
I
D'Agostino
S
S
Lauricella
S
S
Musicò
M
M
Orlandi
F
F
Sammarco
P
P
Maggio
A
A
D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D005500:Follow-Up Studies; D005838:Genotype; D006441:Hemoglobin A / Q000032:analysis; D006801:Humans; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011296:Prenatal Diagnosis / Q000379:methods*; D015203:Reproducibility of Results; D013789:Thalassemia / Q000175:diagnosis* / Q000235:genetics
D006441:Hemoglobin A